Trends in Kidney Cancer Research

PTK787/ZK222584: A Specific VEGF-Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma; Tumour Growth Factor-ss1 (TGF-ss1) Plasma Levels in Patients with Localised and Metastatic Renal Cell Carcinoma; Prognostic and Predictive Implications of CD8highCD57+ Lymphocytes for Advanced Renal Cell Carcinoma Patients; Thrombin Receptors in Renal Carcinoma Cells; Upper Urinary Tract Carcinoma after Intake of Aristolochia Fangchi: Value of Urinary Cytology in End-Stage "Chinese-Herb Nephropathy"; Nephrectomy and Resection of the Liver with the Inferior Vena Cava for Recurrences of Adrenal Cortical Carcinoma over Ten Years after the Adrenalectomy: Report of a 14-year-survived Case with Good Quality of Life; Quality of Life of Metastatic Renal Carcinoma Patients Receiving Subcutaneous Interferon or Intravenous Interleukin-2; Implementation of a Web-Based Clinical Pathway for Radical Nephrectomy to Improve Health Outcomes; Surgical Management of Renal Cell Carcinoma with Inferior Vena Cava Tumour Thrombus and Review of the Literature; A Critical Review: A New Trial to Overcome the Multi-drug Resistance of Renal Cell Carcinoma: From Theoretical Possibility to Therapeutic Benefit?; Surviving as Indicator of Diagnosis and Progression in Transitional Cell Carcinoma.